Antoine Yver

Antoine Yver currently works at Sanofi, as Independent Director from 2022, Spotlight Therapeutics, Inc., as Director from 2022, and Stipple Bio Inc., as Director.
Dr. Yver also formerly worked at Centessa Pharmaceuticals Plc, as Executive Vice President & Chairman-Development from 2022 to 2024, Aventis SA, as Senior Director-Clinical Research from 1990 to 2005, Schering-Plough SAS, as Executive Director-Oncology from 2006 to 2009, Johnson & Johnson Medical SAS, as Senior Director-Oncology from 2005 to 2006, AstraZeneca PLC, as Head-Global Medicines Development from 2015 to 2016, and Daiichi Sankyo Co., Ltd., as EVP, Global Head-Oncology Research and Development from 2016 to 2021.
Dr. Yver received his undergraduate degree and doctorate degree from Université Paris-Saclay.